Pharmazz, Inc.
Clinical trials sponsored by Pharmazz, Inc., explained in plain language.
-
New hope for Brain-Damaged newborns: drug may prevent disability
Disease control Recruiting nowThis study tests a drug called sovateltide in 40 newborns with brain injury from lack of oxygen at birth. The drug aims to help the brain repair itself and reduce the risk of death or long-term disability. Current standard treatment (cooling) has limited success, so researchers h…
Phase: PHASE2 • Sponsor: Pharmazz, Inc. • Aim: Disease control
Last updated May 17, 2026 07:54 UTC
-
New stroke drug shows promise in major US trial
Disease control Recruiting nowThis study tests a new drug called sovateltide for people who have had a stroke caused by a blood clot in the brain. The goal is to see if it helps patients recover better and have less disability. About 514 adults aged 18 to 80 will receive either the drug or a placebo, along wi…
Phase: PHASE3 • Sponsor: Pharmazz, Inc. • Aim: Disease control
Last updated May 17, 2026 07:51 UTC
-
Could a new drug help stroke patients recover better?
Disease control Recruiting nowThis study tests a drug called sovateltide in 160 adults who had a stroke caused by a blocked blood vessel in the brain. The goal is to see if the drug is safe and helps improve recovery, such as being more independent. Participants receive the drug or a placebo within 24 hours o…
Phase: PHASE4 • Sponsor: Pharmazz, Inc. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Breakthrough drug trial aims to save lives from fatal blood loss
Disease control Recruiting nowThis study is testing whether adding a new drug called LYFAQUIN to standard emergency care helps patients with life-threatening shock from severe blood or fluid loss. About 400 adult patients with very low blood pressure will receive the drug along with usual treatments like IV f…
Phase: PHASE4 • Sponsor: Pharmazz, Inc. • Aim: Disease control
Last updated Apr 20, 2026 16:16 UTC